EUVIMEDEUVIMED entdecken
Crossref

Swietenine attenuates renal tubular injury by activating mitophagy in diabetic nephropathy

Feilong Pei, Jingyu Duan, Lin Tan, Cuicui Gu, Jiale Miao, Shuang Liu, Chunping Zhang

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2025.157668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Feilong Pei und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. Electronic address: 3481260781@qq.com. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Mitophagy, Kidney Tubules. Die Arbeit nennt 74 Literaturangaben. Gefördert von: Science and Technology Support Program of Jiangsu Province, Jiangsu Province Natural Science Foundation, Xuzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetic nephropathy (DN) is a common complication of diabetes, characterized by high prevalence and mortality rates. Tubular damage is a significant pathological aspect of DN. Mitophagy plays a crucial role in tubular damage associated with DN. Swietenine (Swi) is the main bioactive compound isolated and purified from the fruits of S. macrophylla, and it has been shown to have anti-inflammatory, antioxidant, and anti-diabetic activities. Previous studies have indicated that Swi provides strong kidney protection in DN, but the underlying mechanisms by which Swi influences DN remain unclear. OBJECTIVE: This study aims to clarify the renal protective effects of Swi during the development of DN and explore its potential molecular mechanisms. METHODS: This study used high-fat diet and streptozotocin (HFD/STZ)-induced DN mice as an in vivo model, and human renal tubular epithelial cells (HK-2 cells) treated with high glucose combined with palmitic acid (HG/PA) as an in vitro model. After 8 weeks of treatment with Swi, serum and urine levels of renal function-related indicators were measured. Renal tissue sections were subjected to histopathological staining, and changes in mitochondrial morphology and number were observed using transmission electron microscopy (TEM). Levels of proteins associated with oxidative stress, apoptosis, autophagy, and mitophagy-related proteins were measured through via Western blotting (WB), immunofluorescence (IF) staining, flow cytometry, and fluorescent probes. Proteomics results based on tandem mass tag (TMT) were used to explore the potential mechanisms of Swi in DN. Finally, siRNA transfection was used to reveal the role of the Acsf2/PHB2/PINK1 pathway in HK-2 cells treated with HG and PA. RESULTS: Swi improved renal function in diabetic mice and alleviated insulin resistance, oxidative stress, and apoptosis levels in DN mice. Swi alleviated tubular injury and enhanced mitophagy levels in both in vivo and in vitro models. Additionally, Swi reduced mitochondrial reactive oxygen species (ROS) production and restored mitochondrial function. Importantly, the protective effects of Swi on HG/PA-induced HK-2 cells was abolished after siRNA transfection and the use of the mitophagy inhibitor Mdivi-1, further confirming that Swi alleviates diabetic kidney tubular injury by activating the Acsf2/PHB2/PINK1 signaling pathway. CONCLUSION: Swi enhances mitophagy through the Acsf2/PHB2/PINK1 pathway to alleviate diabetic kidney tubular damage. This study provides new evidence that Swi could be a potential drug for preventing and treating DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMitophagyKidney TubulesAnimalsHumansMiceMaleDiabetes Mellitus, ExperimentalMice, Inbred C57BLOxidative StressCell LineDiet, High-FatApoptosisMitochondriaStreptozocin

Stichwörter der Autor:innen

Acsf2/PHB2/PINK1Diabetic nephropathyMitophagySwietenine

Substanzen

Streptozocin

Autor:innen und Institutionen

  • School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. Electronic address: 3481260781@qq.com.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. Electronic address: 1483069698@qq.com.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. Electronic address: 2177925288@qq.com.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. Electronic address: 2728876523@qq.com.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. Electronic address: 1009194100@qq.com.

Förderung

  • Science and Technology Support Program of Jiangsu Province
  • Jiangsu Province Natural Science Foundation
  • Xuzhou Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Pei, F., Duan, J., Tan, L., Gu, C., Miao, J., Liu, S., & Zhang, C. (2026). Swietenine attenuates renal tubular injury by activating mitophagy in diabetic nephropathy. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157668

Vancouver

Pei F, Duan J, Tan L, Gu C, Miao J, Liu S, et al. Swietenine attenuates renal tubular injury by activating mitophagy in diabetic nephropathy. Phytomedicine. 2026. doi:10.1016/j.phymed.2025.157668

BibTeX
@article{Pei2026,
  author = {Pei, Feilong and Duan, Jingyu and Tan, Lin and Gu, Cuicui and Miao, Jiale and Liu, Shuang and Zhang, Chunping},
  title = {Swietenine attenuates renal tubular injury by activating mitophagy in diabetic nephropathy},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2025.157668}
}
Kostenlos starten →